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Abstract
Purpose To report the 2-year outcomes of a novel surgical technique allowing reduction of the intraluminal diameter of the tube
without total tube occlusion in order to allow enough increase in outflow resistance to permit resolution of hypotony whilst also
achieving adequate IOP control.
Methods This was a single-surgeon retrospective case note review of all non-valved GDD cases over an 8-year period (2008–
2015) that underwent ab interno ligation of the drainage tube in order to manage post-operative hypotony (Baerveldt orMolteno).
Twelve eyes of 12 patients (4.4%) developing refractory hypotony that did not respond to multiple intracameral ophthalmic
viscoelastic device (OVD) injections were included in this retrospective case series and were treated with our ab interno tube
ligation technique. The post-ligation management algorithm consisted of re-instating topical anti-glaucoma agents, laser suture
lysis (LSL), or further ab interno ligation.
Results Mean IOP increased from 2.8 mmHg at baseline to 7.8 mmHg, 7.1 mmHg, 9.0 mmHg, 13.6 mmHg, 10.9 mmHg,
13.9 mmHg and 13.6 mmHg at day 1, week 1, month 1, month 3, month 6, year 1 and year 2 respectively, with or without
additional topical anti-glaucoma medications. Although hypotony resolution following our technique was achieved in all eyes at
2 years, 8.3% of cases required reinstatement of topical medications to maintain IOP control within the target range.
Conclusions We propose ab interno partial tube tying as an effective surgical option to achieve an immediate, predictable and
sustained IOP elevation either as a primary procedure or when traditional methods have failed to resolve hypotony in eyes with
non-valved GDDs.
Keywords Non-valved glaucoma drainage device . Hypotony . Glaucoma . Tube ligation
Introduction
Ocular hypotony following non-valved glaucoma drainage
device (GDD) implantation can lead to sight-threatening hy-
potony-related complications (HRCs). The management can
be challenging, requiring injections of ocular viscoelastic de-
vices (OVDs) [1], total occlusion of the drainage tube using a
ligating suture, or removal of the drainage tube from the an-
terior chamber [2].
Total ligation or removal of the tube may however cause
excessive increase in intraocular pressure (IOP) and further
jeopardize the already compromised optic nerve in these eyes.
There is often a volatility in the fluctuation of IOP in these
complex eyes, which are challenging to manage without caus-
ing serious permanent damage to vision. Restoring the fine
balance between aqueous production and outflow is hence
paramount in the successful treatment of refractory hypotony
following non-valved GDD implantation.
We therefore developed a novel ab interno partial ligation
technique that aims to reduce the intraluminal diameter of the
tube without total tube occlusion, so that outflow resistance is
increased enough to allow resolution of hypotony without
causing a rebound spike in IOP. To the best of the authors’
knowledge, this is the first study to describe such a technique
and report its long-term outcomes in eyes with refractory
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hypotony following either Baerveldt or Molteno GDD im-
plantation for complex glaucoma.
Methods
Patient selection
This was a single-surgeon retrospective case note review of all
non-valved GDD cases over an 8-year period (2008–2015)
that underwent ab interno ligation of the drainage tube in order
to manage post-operative hypotony. All cases were refractory
to multiple fixed-volume intracameral injections of sodium
hyaluronate 1.4% at the slit-lamp, our preferred initial inter-
vention for early post-operative hypotony after non-valved
GDDs [1]. Either a Baerveldt (Abbott Laboratories Inc.,
Abbott Park, IL, USA) or a Molteno (Molteno Ophthalmic
Ltd., Dunedin, New Zealand) drainage device was used in
all cases. Baerveldt implants were either 250 mm2 or
350 mm2 in size depending on the ocular history and risk of
post-operative hypotony.
A standard surgical technique was performed for implan-
tation of the GDD in all cases, as has been previously de-
scribed [3]. In brief, all cases had placement of a full-length
intraluminal occluding 3/0 polyamide stent suture (Supramid,
S. Jackson Inc., Alexandria, VA, USA) as well as external tube
ligation with a 6/0 polyglactin absorbable suture, to prevent
excessive early postoperative filtration. All cases also had a
0.5-mm-long Sherwood tube fenestration slit made just ante-
rior to the occlusive 6/0 ligature to allow some modulation of
early post-operative IOP until dissolution of the ligature in
about week 6.
Ab interno tube ligation technique
Two 9/0 prolene sutures were tied around the intracameral
portion of the tube using slip-knots. For the first tie a 6/0
prolene suture was placed within the tube lumen whilst tight-
ening the knot, and then removed. The second tie was placed
in the same way, but using a 7/0 prolene suture within the tube
lumen, as illustrated in the schematic (Fig. 1). This was done
under the operating microscope. Each intraluminal prolene
suture acted as a ‘spacer’, allowing a consistent graduated
reduction of the tube gauge, with the proximal portion of the
tube becoming narrower than its distal portion. The aimwas to
achieve a graduated reduction in the intraluminal diameter of
the tube without total tube occlusion.
The ties were placed intra-camerally without externalizing
the tube, via two paracenteses on either side of the tube entry
site (Fig. 2a). Another paracentesis was made at the limbus
opposite to the tube position to allow the intraluminal prolene
suture to pass straight into the lumen of the tube (Fig. 2a). A
9/0 prolene suture needle was passed through from one
paracentesis to exit the second paracentesis by docking into
a 25-gauge needle introduced via the second paracentesis. The
25-gauge needle then guided the prolene suture needle out of
the second paracentesis, leaving the suture passing on the
posterior side of the tube. Using an intraocular manipulator
(Sung manipulator, Altomed Limited, Tyne and Wear, UK),
the 9/0 prolene suture was then looped over the tube and
brought out through the first paracentesis similar to the
Siepser slip-knot technique [4]. A three-throw slip-knot was
then fashioned outside the eye, slid inside the anterior cham-
ber and tied tightly with 2 micro needle-holders on the poste-
rior side of the tube. The tightness of the knot was tested by
pulling the intra-luminal spacer suture gently to make sure that
the knot was tight enough to narrow the lumen to the size of
the spacer suture. Another double-throw knot was then tied to
lock the knots in position. The threads of the suture were then
cut with 23-gauge intra-ocular scissors. The first 6/0 spacer
suture was then removed from the tube lumen and replaced
with a 7/0 prolene spacer suture. The whole procedure was
then repeated with another 9/0 prolene suture tied more tightly
and nearer to the proximal end of the tube (Fig. 2b). The 7/0
prolene spacer suture was then removed from the tube lumen.
In some cases, a third total tie was placed at the most proximal
end without an intra-luminal spacer suture to achieve total
occlusion of the tube, depending on the extent of hypotony.
Trypan blue dye was injected through the proximal tube open-
ing using a 30-gauge cannula to check for total tube occlusion
in cases where a third total occlusion tie was placed, and was
confirmed when no dye was observed to pass beyond this tie
(Fig. 2c).
Post-ligation management
We followed a step-wise management strategy following this
procedure. If IOP was deemed too high, pressure-lowering
medications were then introduced back into the treatment re-
gime. If the IOP was still too high, the proximal tighter tie
(nearer to the end of the tube in AC) was cut using
neodymium-doped yttrium aluminium garnet laser suture ly-
sis (LSL) in the outpatient clinic or surgically in theatre. If,
however, the IOP did not increase following the procedure, a
further totally occluding 9/0 prolene was tied around the tube
without the use of an intra-luminal spacer suture as described
earlier. This final tie could then also be released at a later date
using LSL should the IOP then rebound too high.
Success was defined as resolution of hypotony with or
without a rebound rise in IOP above 22mmHg, and resolution
of hypotony related complications. Complications of the pro-
cedure were recorded at each time point, including uncon-
trolled IOP rise requiring LSL, untying of one or more liga-
tures, or repeat ab interno tube ligation for unresolved hypot-
ony. Persistent hypotony, choroidal or retinal detachments,
endophthalmitis or phthisis, as well as development of
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visually significant cataracts, cystoid macular oedema (CMO)
or epiretinal membrane (ERM) were recorded over a 2-year
follow-up period.
The study was part of a larger retrospective study of the
outcomes of glaucoma surgical intervention approved by the
local Research Ethics Committee (reference: 12/WM/0158)
and adhered to the tenets of the Declaration of Helsinki.
Descriptive statistical analyses were performed using IBM
SPSS Statistics version 23.0.
Results
During the study period, 271 non-valved (Baerveldt or
Molteno implants) GDD implant surgeries were performed
by the authors’ team (VS). Of these, 12 eyes of 12 patients
(4.4%) developed refractory hypotony that did not respond to
multiple intracameral OVD injections and were included in
this retrospective case series. Four cases were in paediatric
patients (< 18 years of age at the time of GDD surgery).
Table 1 shows baseline patient demographics.
All eyes were on maximum tolerated medical therapy for
their glaucoma prior to undergoing GDD implantation, with a
mean of 4.3 (± 0.9) anti-glaucoma medications and a mean
cup: disc ratio of 0.8 (± 0.1). Prior to tube-tying, 10 eyes
(83.3%) had choroidal detachment or maculopathy due to re-
fractory hypotony.
Mean IOP increased from 2.8 mmHg (± 2.3) prior to ab
interno tube ligation to 7.8 mmHg (± 5.8) at day 1. This rise
persisted long-term with resolution of hypotony in all cases
(Fig. 3), with mean IOP measuring 7.1 mmHg (± 6.4),
9.0 mmHg (± 7.8), 13.6 mmHg (± 5.8), 10.9 mmHg (± 9.4),
13.9 mmHg (± 6.7) and 13.6 mmHg (± 6.5) at week 1, month
1, month 3, month 6, year 1 and year 2 respectively, with or
without additional topical anti-glaucoma medications.
Hypotony resolution at 2 years was achieved in all eyes at
2 years, with no significant rebound IOP rise in 83.3% (10
eyes). Topical medications to maintain IOP control within
target were reinstated in 16.7% (2 eyes). The change in
BCVA over time is shown in Fig. 4.
Table 2 shows the number of additional interventions re-
quired over 2 years of follow-up following this technique.
Fig. 1 Schematic of partial internal tube tying technique
Fig. 2 Intra-operative images showing a the 6/0 prolene spacer suture, b a second tie with 9/0 prolene suture and c confirmation of total occlusion which
was required in some cases, via injection of trypan blue dye. White arrows = tube ties. Black arrow = intraluminal spacer suture
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Only one case (8.3%) resolved without any further proce-
dures. Five (41.6%) required further OVD injections into the
AC. Two-thirds (66.7%) required further partial or total tying
of tube with the same ab interno technique. Two-thirds
(66.7%) required untying of one or more sutures either surgi-
cally or by LSL to lower the IOP. The hypotony resolved in all
cases before the end of the 24-month follow-up period. One
eye developed retinal detachment likely secondary to previous
trauma, and there were no cases of phthisis or endophthalmi-
tis. Of the five phakic eyes, four (80%) required cataract sur-
gery after tube tying. Of these, two eyes were rendered
aphakic whilst the other two had intraocular lens implantation.
Visual acuity improved in all four eyes undergoing cataract
extraction, with a mean pre- and post-phacoemulsification
BCVA of 1.34 ± 0.6 and 0.49 ± 0.5 logMAR respectively.
Discussion
We achieved IOP control without the need to recommence any
anti-glaucomamedications in 83.3% (10/12) of eyes. Two eyes
required recommencement of medications. The first had a his-
tory of juvenile glaucoma and was commenced back on glau-
coma drops at year 2 (fixed combination of dorzolamide/
timolol 0.5% and bimatoprost 0.01%), though this was still
significantly fewer than the four topical agents plus oral acet-
azolamide that was required originally. This patient required
total tube ligation due to persistent cystoid macular oedema.
The second had a history of microphthalmos and vitrectomy
with silicone oil tamponade in situ following retinal detach-
ment, and required a fixed combination of brinzolamide/
timolol to achieve target IOP having been on four topical
agents plus oral acetazolamide prior to GDD implantation.
Visual acuities did not significantly improve despite resolu-
tion of hypotony in our series. In some cases, visual acuity
actually worsened. This was due to the development of visu-
ally significant cataracts in 80% of the phakic eyes in our series
(4 of 5 eyes) as well as retinal detachment requiring vitrectomy
and oil in one eye. One pseudophakic eye required laser
capsulotomy for posterior capsular opacification, two eyes de-
veloped significant ERM (of which one later underwent pars
plana vitrectomy), and one eye developed early post-operative
CMO treated successfully with orbital floor triamcinolone.
This same eye developed corneal decompensation and later
underwent endothelial lamellar keratoplasty 5 years after tube
tying. There were no other cases of corneal decompensation in
our series, and hypotony related maculopathy or choroidal de-
tachments resolved in all cases. It is important to also note that
all eyes had advanced glaucomatous optic neuropathy which
would contribute to the gradual decline in BCVA over the post-
operative follow-up period.
The Ahmed versus Baerveldt Study demonstrated that non-
valved glaucoma tube shunts achieve a greater reduction in
IOP and glaucoma medications at 5 years, as well as lower
failure rates when compared to valved shunts [5]. However,
non-valved shunts have a greater 5-year risk of hypotony and
its related complications when compared to valved shunts [5,
6]. Although early hypotony following non-valved GDDs has
been reported to occur in as much as 39% of eyes [3, 7], the
incidence of persistent hypotony is far less common, with
reports in the literature ranging from 0% to 13%, which is in
Table 1 Patient demographics and clinical characteristics
General
Eyes, n 12
Males/females, n (%) 7 (58)/5 (42)
Mean age, years, (range) 33.9 (8.6–66.0)
Mean time to partial tube ligation, months, (± SD) 3.3 (± 3.7)
Primary glaucoma diagnosis, n, (%)
Uveitic 5 (42)
JIA 2
Steroid induced 1
FHC 1
Sympathetic panuveitis 1
Neovascular (due to PDR) 2 (17)
Angle recession 2 (17)
Post-vitrectomy and oil 1 (8)
Pseudoexfoliation 1 (8)
Aphakic glaucoma/nanophthalmos 1 (8)
Previous incisional surgery, n (%)
Trabeculectomy surgery 3 (25)
ECCE 1 (8)
Phacoemulsification 5 (42)
Pars plana vitrectomy 1 (8)
Previous TSCD treatment, n (%) 4 (33)
Of which 1 prior TSCD 2
Of which 2 prior TSCD 1
Of which 3 prior TSCD 1
In neovascular glaucoma 2
In angle recession 1
In pseudoexfoliation 1
In uveitic eyes 0
Type of GDD, n (%)
Molteno 2 (17)
Baerveldt 350 mm2 5 (42)
Baerveldt 250 mm2 5 (42)
MMC not used, n (%) 2 (17)
MMC used, n (%) 10 (83)
0.2 mg/ml for 3 min 6
0.4 mg/ml for 3 min 3
0.4 mg/ml for 5 min 1
GDD, glaucoma drainage device; PDR, proliferative diabetic retinopathy;
JIA, juvenile idiopathic arthritis; FHC, Fuch’s heterochromic cyclitis;
TSCD, trans-scleral ciliary body cyclodiode
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keeping with our rate of 4.4% [6, 8–10]. The variation is likely
to be due to a difference in case-mix between studies, with
those studies having higher proportions of complex eyes
(chronic uveitis, trauma, prior cyclo-destructive procedures
or neovascular glaucoma) being more likely to have greater
rates of persistent hypotony.
Despite the well-known risk of persistent hypotony after
GDD surgery, few studies have reported on the outcomes of
surgical management of these cases. Common practice is to
use intracameral injections of OVD or total ligation of the
external portion of the drainage tube using non-absorbable
sutures [8]. The former option may require multiple injections
of OVD due to their short-lived effect, although more viscous
devices such as reticulated hyaluronic acid have recently been
used to prevent phthisis and maintain aesthetic appearance in
pre-phthisical blind eyes with chronic hypotony [11]. One
third of our cases had previous cyclo-destructive procedures,
which may explain the poor resolution of hypotony in these
eyes using fixed-volumes of repeated intracameral OVD
injections.
Recent studies have described a controlled reduction of
outflow restriction using LSL after Baerveldt tube surgery
and graduated intraluminal stent removal to achieve low rates
of hypotony-related complications [8]. Techniques used to
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Fig. 3 Mean IOP and number of
anti-glaucoma medications before
tube surgery, prior to partial tying
of tube, and at various time points
after partial tying of tube. Error
bars represent 95% confidence
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Fig. 4 Mean best-corrected
logMAR visual acuity (BCVA)
before tube surgery, prior to par-
tial tying of tube, and at various
time points after partial tying of
tube. Error bars represent 95%
confidence intervals
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treat eyes with HRC in this series included intracameral injec-
tions of OVD and re-insertion of the intraluminal Supramid
stent. A recent case report describes the ab interno placement
of two 5/0 nylon sutures to stent an Ahmed glaucoma valve
without the need for intracameral tube tying in an eye with
neovascular glaucoma [12], with good 6-month outcomes.
Another paper describes the use of a 3/0 Supramid suture
inserted ab interno for two cases of persistent hypotony, but
with limited long-term data [13], whilst another study de-
scribes ab externo insertion of the Xen gel stent into the
GDD tube lumen of two cases with chronic hypotony [14].
However, these techniques alone may not always resolve hy-
potony, particularly in very high-risk cases with volatile aque-
ous production rates [15].
In spite of our graduated technique of narrowing the tube
diameter, it was still difficult to predict which eyes would
recover immediately from the hypotony. We found that 40%
still required further OVD injections and two-thirds required
further ab interno tube tying, mostly with the addition of a
total occlusion tie, to achieve early hypotony resolution.
Table 2 Additional surgical interventions required per case after ab interno partial tying of tube
Patient
age (years)
Diagnosis GDD implanted Number of
prior TSCD
Additional post-ligation interventions Number of
additional
interventions
8.6 Uveitic (JIA related) Molteno 0 Tube repositioning/Repeat partial tube ligation
(month 21)
1
11.8 Uveitic (JIA related) BVT 250 0 Untying of proximal tube tie (month 3)
Repeat partial tube ligation (month 4)
Repeat partial tube ligation (month 5)
LSL of proximal tube tie (month 5)
4
13.1 Uveitic (sympathetic
panuveitis)
BVT 250 0 Repeat partial tube ligation (month 3)
Lensectomy/PPV/untying of distal tie (month 7)
2
36.5 Uveitic (FHC) Molteno 0 Additional partial ligation with a 3rd proximal
tie (week 3)
LSL of 2 proximal tube ties (week 3)
AC paracentesis × 8 (week 3)
Repeat partial tube ligation of 2 distal tube ties
(week 6)
4
59.1 Uveitic (steroid induced) BVT 350 0 HGV into AC (week 1)
Repeat partial tube ligation (week 2)
AC paracentesis (week 2)
LSL of proximal tube tie (week 4)
HGV into AC (week 5)
5
14.5 Angle recession BVT 250 1 HGV into AC (week 5)
PPV/oil for exudative RD (month 7)
ROSO as oil blocking tube (month 8)
Untying of proximal tube tie (month 12)
4
66.0 Angle recession BVT 350 0 HGV into AC (month 5)
Repeat partial tube ligation with 3 × 9/0
(month 16)
Re-insertion of supramid
Repeat partial tube ligation (year 2)
3
18.1 Post-vitrectomy + oil BVT 250 0 Untying of distal tube tie (month 7)
LSL of proximal tube tie (month 10)
2
29.7 NVG BVT 350 2 Nil 0
33.3 NVG BVT 250 3 LSL of proximal tube tie (month 11)
Repeat partial tube ligation (month 11)
Lensectomy (month 9)
3
53.7 Aphakic glaucoma BVT? 350 0 HGV into AC (week 1, week 2, week 5)
Phaco/IOL/GSL (month 4)
4
62.1 PXF/JOAG BVT 350 1 HGV into AC (week 4, week 5, week 8, week
9, week 12)
Total internal tube ligation (month 3)
LSL of tube tie (month 5)
Phaco/IOL/anterior vitrectomy (month 22)
8
JIA, juvenile idiopathic arthritis; FHC, Fuch’s heterochromic uveitis; NVG, neovascular glaucoma; PXF, pseudoexfoliation glaucoma; JOAG, juvenile
open angle glaucoma; GDD, glaucoma drainage device; BVT, Baerveldt tube; TSCD, trans-scleral cyclodiode; LSL, laser suture lysis; AC, anterior
chamber; HGV, Healon GV; PPV, pars plana vitrectomy; ROSO, removal of silicone oil; Phaco, phacoemulsification
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This would suggest that a total occlusion tie is necessary in
the majority of cases to completely stop aqueous drainage,
allowing ciliary body function and thus the IOP to recover.
Conversely when the hypotony did recover, two-thirds of
eyes required subsequent LSL or untying of one or more
suture ties over the following months because of raised
IOP. We believe this is to be expected because of the nature
of such complex eyes, in which there is a fine, individual-
ized, and volatile balance between the degree of ciliary
body dysfunction, aqueous production, and outflow
resistance.
Having a clear step-wise management strategy with
close patient follow-up allowed us to respond to changes
in IOP in a methodical manner whilst avoiding serious
complications. Our LSL technique allows selective and
stepwise release of the ties to minimize the risk of recurrent
hypotony in these eyes. The delicate balance in these eyes
is further reflected by the fact that despite our stepwise
strategy, three cases (25%) required repeat ab interno tying
of the tube.
Although some surgical techniques to deal with refrac-
tory hypotony have been described in academic meetings,
to the best of our knowledge there have been no publica-
tions on their medium to long-term outcomes. Those de-
scribed either require conjunctival dissection prior to liga-
tion of the external portion of the tube, or externalization of
the intracameral portion of the tube via a full-thickness
corneal incision over the tube opening. The former tech-
nique carries the risk of inciting further conjunctival in-
flammation and scarring, and makes later adjustment of
this ligating suture difficult if the IOP then elevates exces-
sively. The latter technique can potentially alter the tube
position causing tube adhesion to the cornea and subse-
quent corneal endothelial damage, given that studies have
shown accelerated rates of endothelial cell loss when the
tube is positioned close to the endothelium [16]. In addi-
tion, a short corneal wound to gain access to the tube
makes water-tight wound closure difficult, increasing the
risk of leakage and its associated complications including
epithelial ingrowth.
We used Mitomycin C (MMC) during GDD implantation
in 83% of eyes in this series, based on a previous study that
demonstrated that intraoperative use of MMC was not signif-
icantly associated with hypotony or low IOP at 3 and 5 years
[3]. Our experience is that early hypotony within the first
3 months is due to over-drainage rather than MMC use.
The main weakness of this study is its retrospective nature
and the relatively small number of the cases. However, it
would take a long time to accumulate a substantially larger
sample size given the low reported rates of persistent hypot-
ony and our considerable experience in developing a safe
GDD implantation technique aimed at keeping hypotony rates
to a minimum.
Conclusions
We developed a novel-graduated ab interno tube ligation tech-
nique and post-ligation management strategy to manage re-
fractory hypotony in high-risk eyes fitted with non-valved
GDDs without the need for conjunctival incisions or external-
ization of the tube. Our series demonstrates high safety and
efficacy at medium-term follow-up and we therefore propose
our technique as an effective option to achieve immediate and
sustained IOP elevation either as a primary procedure or when
traditional methods (intracameral viscoelastic injections or re-
insertion of intraluminal stents) have failed to resolve hypot-
ony in eyes with non-valved GDDs.
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